Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

The products, available for less than £4 at high-street chemists and supermarkets, have become many patients' go-to remedy ...

1. In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

Dr. Israel Francis “Ish” Paragas, the spokesperson of PhilHealth, said the change is expected to ease the burden on vulnerable groups, especially patients undergoing extended treatment or suffering ...

Spray it ain’t ... along the sides of your nasal passage — as “that’s where all the inflamed tissues are,” he explained. When it comes to allergy relief, spraying your septum is pretty ...

There’s no doubt that many have experienced the relief – or dread – that comes with the nkum nkum sound when satisfying that nasal itch. Chronic sinus issues that cause congestion, infections and ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Zavegepant 10 mg nasal spray provided rapid and safe relief from acute migraine attacks but did not exhibit long-term superiority over oral calcitonin gene-related peptide receptor antagonists.

Aerin Medical, Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of positive three-year results from VATRAC, a randomized controlled ...

Since allergy season arrives at roughly the same time every year, Leftwich recommends starting your allergy relief of choice ... eye drop, or nasal spray forms. Antihistamines help reduce ...

Milestone® Pharmaceuticals (NASDAQ:MIST) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for its New Drug Application (NDA) for CARDAMYST™ ...

March 28 (Reuters) - Milestone Pharmaceuticals (MIST.O), opens new tab said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of heart condition and had ...